Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Mar 15, 2025; 16(3): 94491
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.94491
Table 4 Multivariate logistical regression analyses depicting the association of glycemic indicators and early neurological outcomes in the patients with and without diabetes
ParameterEarly neurological deterioration
Early neurological improvement
OR
95%CI
P value
OR
95%CI
P value
Patients with DM1
Admission hyperglycemia1.9541.061-3.6010.0320.7230.356-1.4680.369
Fasting blood glucose
First quartileReferenceReferenceReferenceReferenceReferenceReference
Second quartile2.2200.782-6.2990.1340.9210.340-2.4940.871
Third quartile2.0250.758-5.4060.1590.9400.369-2.3970.897
Fourth quartile3.9241.568-9.8160.0030.7480.299-1.8750.536
Fasting blood glucose
First quartileReferenceReferenceReferenceReferenceReferenceReference
Second quartile3.6201.743-7.7340.0021.9320.973-6.9100.063
Third quartile2.8261.143-6.9900.0251.2030.470-3.0780.699
Fourth quartile5.7442.410-9.8310.0011.5360.567-4.1620.398
Patients without DM2
Admission hyperglycemia1.6021.027-2.4990.0381.0550.635-1.7520.837
Fasting blood glucose
First quartileReferenceReferenceReferenceReferenceReferenceReference
Second quartile1.0350.551-1.9440.9140.6710.373-1.2070.183
Third quartile1.6460.894-3.0330.1100.7460.399-1.3930.357
Fourth quartile1.8730.984-3.5650.0560.7390.359-1.5200.411
Fasting blood glucose
First quartileReferenceReferenceReferenceReferenceReferenceReference
Second quartile1.9040.975-3.7190.0591.6350.890-3.0040.113
Third quartile2.2631.155-4.4340.0170.9300.472-1.8320.834
Fourth quartile2.9081.521-5.5560.0011.0900.547-2.1750.806